{
    "id": "5e2b253ffbd6abf43b000006",
    "question": "Is AZD5153 active in prostate cancer?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "A",
    "predict": "{\"step_by_step_thinking\": \"To determine whether AZD5153 is active in prostate cancer, I need to look up the latest information on this compound. AZD5153 is a small molecule inhibitor of the PI3K/mTOR pathway, which is often dysregulated in various cancers, including prostate cancer. Research on this compound is still ongoing, but as of my knowledge cutoff, there is evidence suggesting that AZD5153 has shown anti-tumor activity in preclinical studies against prostate cancer cells. This includes inhibiting cell proliferation, inducing apoptosis, and suppressing angiogenesis. However, the clinical efficacy and safety of AZD5153 in prostate cancer patients have not been extensively evaluated. Therefore, based on the available preclinical data, I would lean towards the affirmative but with the caveat that more research is needed to confirm its clinical utility.\", \"answer_choice\": \"A\"}",
    "snippets": [],
    "scores": [],
    "execution_time": 15.368290662765503
}